^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MGY825

    i
    Other names: MGY825, MGY-825, MGY 825
    Associations
    News
    Trials
    Company:
    Novartis
    Drug class:
    NRF2 inhibitor, CUL3 inhibitor, KARS inhibitor, KEAP1 inhibitor
    Related drugs:
    Associations
    News
    Trials